Adequan i.m. is an FDA-Approved drug for the treatment of DJD and traumatic joint dysfunction. As required by the FDA, safety and efficacy studies were contudcted on Adequan i.m. without concomitant used of additional products. Adequan i.m. successfully achieved FDA-apprroval without use of additional oral joint health (OJS) products.